 Ventricular Dysfunction, Left
"Ventricular Dysfunction, Left" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Descriptor ID |
D018487
|
| MeSH Number(s) |
C14.280.945.900
|
| Concept/Terms |
Ventricular Dysfunction, Left- Ventricular Dysfunction, Left
- Left Ventricular Dysfunction
- Dysfunction, Left Ventricular
- Dysfunctions, Left Ventricular
- Left Ventricular Dysfunctions
- Ventricular Dysfunctions, Left
|
Below are MeSH descriptors whose meaning is more general than "Ventricular Dysfunction, Left".
Below are MeSH descriptors whose meaning is more specific than "Ventricular Dysfunction, Left".
This graph shows the total number of publications written about "Ventricular Dysfunction, Left" by people in this website by year, and whether "Ventricular Dysfunction, Left" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 | | 1994 | 1 | 0 | 1 | | 1995 | 0 | 1 | 1 | | 1996 | 1 | 1 | 2 | | 1997 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2006 | 3 | 3 | 6 | | 2007 | 1 | 0 | 1 | | 2009 | 1 | 1 | 2 | | 2010 | 0 | 2 | 2 | | 2011 | 2 | 0 | 2 | | 2012 | 1 | 3 | 4 | | 2013 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2016 | 6 | 1 | 7 | | 2017 | 1 | 0 | 1 | | 2018 | 2 | 0 | 2 | | 2019 | 2 | 0 | 2 | | 2020 | 0 | 1 | 1 | | 2021 | 1 | 0 | 1 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ventricular Dysfunction, Left" by people in Profiles.
-
Park DY, An S, Attanasio S, Jolly N, Malhotra S, Doukky R, Samsky MD, Sen S, Ahmad T, Nanna MG, Vij A. Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction. Am J Cardiol. 2023 01 15; 187:84-92.
-
Yan J, Killingsworth C, Walcott G, Zhu Y, Litovsky S, Huang J, Ai X, Pogwizd SM. Molecular remodeling of Cx43, but not structural remodeling, promotes arrhythmias in an arrhythmogenic canine model of nonischemic heart failure. J Mol Cell Cardiol. 2021 09; 158:72-81.
-
Ravi V, Hanifin JL, Larsen T, Huang HD, Trohman RG, Sharma PS. Pros and Cons of Left Bundle Branch Pacing: A Single-Center Experience. Circ Arrhythm Electrophysiol. 2020 12; 13(12):e008874.
-
Prabhu N, Patel H, Golemi L, Fogg L, Cobleigh M, Okwuosa T. Trastuzumab-induced cardiac toxicity: Is serial assessment of left ventricular ejection fraction during treatment necessary? Breast J. 2020 05; 26(5):1085-1086.
-
Shah S, Benedetto U, Caputo M, Angelini GD, Vohra HA. Comparison of the survival between coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with poor left ventricular function (ejection fraction <30%): a propensity-matched analysis. Eur J Cardiothorac Surg. 2019 02 01; 55(2):238-246.
-
Mohammad Nijres B, Bokowski J, Al-Kubaisi M, Abdulla RI, Murphy JJ, Awad S, Diab KA. Use of Speckle Tracking Echocardiography to Assess Left Ventricular Systolic Function in Patients with Surgically Repaired Tetralogy of Fallot: Global and Segmental Assessment. Pediatr Cardiol. 2018 Dec; 39(8):1669-1675.
-
Trohman RG, Sharma PS. Detecting and managing device leads inadvertently placed in the left ventricle. Cleve Clin J Med. 2018 Jan; 85(1):69-75.
-
Mohamedali B, Yost G, Bhat G. Is Diabetes Mellitus a Risk Factor for Poor Outcomes after Left Ventricular Assist Device Placement? Tex Heart Inst J. 2017 Apr; 44(2):115-119.
-
Quyyumi AA, Vasquez A, Kereiakes DJ, Klapholz M, Schaer GL, Abdel-Latif A, Frohwein S, Henry TD, Schatz RA, Dib N, Toma C, Davidson CJ, Barsness GW, Shavelle DM, Cohen M, Poole J, Moss T, Hyde P, Kanakaraj AM, Druker V, Chung A, Junge C, Preti RA, Smith RL, Mazzo DJ, Pecora A, Losordo DW. PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. Circ Res. 2017 Jan 20; 120(2):324-331.
-
Brann AM, Cobleigh MA, Okwuosa TM. Cardiovascular Monitoring With Trastuzumab Therapy: How Frequent Is Too Frequent? JAMA Oncol. 2016 Sep 01; 2(9):1123-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|